University of Thessaly clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.
- Notable: SWITCH-ARDS · Switch in Moderate ARDS Recruitment opened
-
Minor: 2 trials marked Unknown by the registry's verification sweep Changed
- Minor: GENSA · Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin · Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) Changed Registry marked status Unknown (sponsor has not verified the record since Jan 2022); last known: Recruiting
- Minor: Physiotherapist's Communication Skills on Clinical Outcomes in Chronic Musculoskeletal Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Hybri-D · Exercise Training and Vitamin D Metabolism Study completion pushed from Jul 20, 2026 to Dec 15, 2026
- Minor: Communication-Focused Pain Neuroscience Education in Chronic Musculoskeletal Pain Primary completion pushed from Aug 30, 2026 to Nov 30, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-30 | NCT07907276 Early Switch in Moderate ARDS | Recruiting |
Active trials by phase
| Early Phase 1 | 1 |
Not charted: 37 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 13
Obesity (4) · Pancreatic Cancer (3) · Ankylosing Spondylitis (1) · Anxiety (1) · Chronic Kidney Disease (1) · Coronary Artery Disease (1) · Diabetes (1) · Heart Disease (1) · Psoriasis (1) · Psoriatic Arthritis (1)
Get alerts when University of Thessaly's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.